An inverse relation between increased Glial fibrillary acidic protein (GFAP) and reduced GLT1 is described in AD with disease progression as defined by Braak stage of NFT pathology (Simpson et al., 2010, 2011). Here, SLC1A2 is linked to Alzheimer disease.